EE03382B1 - Tsüstiini mõnede derivaatide farmakoloogiline kasutamine - Google Patents

Tsüstiini mõnede derivaatide farmakoloogiline kasutamine

Info

Publication number
EE03382B1
EE03382B1 EE9700229A EE9700229A EE03382B1 EE 03382 B1 EE03382 B1 EE 03382B1 EE 9700229 A EE9700229 A EE 9700229A EE 9700229 A EE9700229 A EE 9700229A EE 03382 B1 EE03382 B1 EE 03382B1
Authority
EE
Estonia
Prior art keywords
pharmacological use
cystine derivatives
cystine
derivatives
pharmacological
Prior art date
Application number
EE9700229A
Other languages
English (en)
Estonian (et)
Other versions
EE9700229A (et
Inventor
Bergstrand H�kan
Pettersson Knut
Christer Westerlund Rolf
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700229A publication Critical patent/EE9700229A/xx
Publication of EE03382B1 publication Critical patent/EE03382B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700229A 1995-03-14 1996-03-12 Tsüstiini mõnede derivaatide farmakoloogiline kasutamine EE03382B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives
PCT/SE1996/000320 WO1996028149A1 (en) 1995-03-14 1996-03-12 The pharmacological use of certain cystine derivatives

Publications (2)

Publication Number Publication Date
EE9700229A EE9700229A (et) 1998-04-15
EE03382B1 true EE03382B1 (et) 2001-04-16

Family

ID=20397536

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700229A EE03382B1 (et) 1995-03-14 1996-03-12 Tsüstiini mõnede derivaatide farmakoloogiline kasutamine

Country Status (24)

Country Link
US (1) US5883126A (pt)
EP (1) EP0814798A1 (pt)
JP (1) JPH11501916A (pt)
KR (1) KR19980703055A (pt)
CN (1) CN1183718A (pt)
AR (1) AR002716A1 (pt)
AU (1) AU701287B2 (pt)
BR (1) BR9607225A (pt)
CA (1) CA2214831A1 (pt)
CZ (1) CZ288219B6 (pt)
EE (1) EE03382B1 (pt)
HU (1) HUP9801985A3 (pt)
IL (1) IL117465A (pt)
IS (1) IS4554A (pt)
NO (1) NO974143D0 (pt)
NZ (1) NZ303781A (pt)
PL (1) PL183234B1 (pt)
SE (1) SE9500897D0 (pt)
SK (1) SK282448B6 (pt)
TR (1) TR199700945T1 (pt)
TW (1) TW385249B (pt)
UA (1) UA42830C2 (pt)
WO (1) WO1996028149A1 (pt)
ZA (1) ZA961749B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014306A1 (en) * 1995-10-17 1997-04-24 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (pt) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Medicinal preparations containing a history of cystine
TW221376B (pt) * 1990-06-28 1994-03-01 Astra Ab
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
EP0746202A4 (en) * 1992-01-06 1997-06-25 Health Maintenance Programs COMPOSITION CONTAINING A PHARMACEUTICALLY ACTIVE ANTI-OXIDANT AND METHOD FOR USE IN THE PREVENTION AND TREATMENT OF RESTENOSIS AFTER ANGIOPLASTY
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker

Also Published As

Publication number Publication date
ZA961749B (en) 1996-09-16
WO1996028149A1 (en) 1996-09-19
HUP9801985A3 (en) 2000-07-28
SE9500897D0 (sv) 1995-03-14
HUP9801985A2 (hu) 1998-12-28
US5883126A (en) 1999-03-16
TW385249B (en) 2000-03-21
NZ303781A (en) 2001-03-30
IL117465A0 (en) 1996-07-23
PL322328A1 (en) 1998-01-19
MX9706825A (es) 1997-11-29
BR9607225A (pt) 1998-07-07
TR199700945T1 (xx) 1998-02-21
EE9700229A (et) 1998-04-15
AR002716A1 (es) 1998-04-29
AU701287B2 (en) 1999-01-21
NO974143L (no) 1997-09-09
JPH11501916A (ja) 1999-02-16
IL117465A (en) 2000-07-26
SK282448B6 (sk) 2002-02-05
KR19980703055A (ko) 1998-09-05
PL183234B1 (pl) 2002-06-28
CZ288219B6 (en) 2001-05-16
UA42830C2 (uk) 2001-11-15
CA2214831A1 (en) 1996-09-19
AU5018596A (en) 1996-10-02
CZ280497A3 (cs) 1998-01-14
EP0814798A1 (en) 1998-01-07
SK120797A3 (en) 1998-02-04
NO974143D0 (no) 1997-09-09
CN1183718A (zh) 1998-06-03
IS4554A (is) 1997-08-27

Similar Documents

Publication Publication Date Title
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
IS2268B (is) Gúanín afleiður
DE69611361D1 (de) Chinazolin-derivate
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
NO973455D0 (no) Dermatologisk anvendelse av Vitamin-D-derivater
ATE240307T1 (de) Diarylalkenylamin-derivate
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
MX9102186A (es) Derivados de aminodiol
MX9100049A (es) Derivados de aminodiol
EE9700229A (et) Tsüstiini mõnede derivaatide farmakoloogiline kasutamine
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
BR9609723A (pt) Derivados da tricetona
ATE225347T1 (de) Aza-anthracyclinone-derivate
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate
PT850246E (pt) Derivados nucleosidicos de pirimidina
ATA45796A (de) Lysin-prolin-derivate
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
KR960011685U (ko) 조명등 결합구조
KR970041939U (ko) 부품의 방진체결구조

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20020312